Reply to McNeil et al

Clinical Infectious Diseases

Volumn 51, Issue 7, 2010, Pages 872-873

  Nakada, Haruka ^a   Narimatsu, Hiroto ^b   Tsubokura, Masaharu ^c   Murashige, Naoko ^a   Matsumura, Tomoko ^a   Kodama, Yuko ^a   Kishi, Yukiko ^a   Kami, Masahiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADVERSE DRUG REACTION; DRUG FATALITY; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; JAPAN; LETTER; MEDICAL PERSONNEL; PRIORITY JOURNAL; RISK;

EID: 77957853024     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656296     Document Type: Letter

References (10)

1. Contract between the Minister of Health, Labor and Welfare and medical institutions [in Japanese]. Ministry of Health, Labor and Welfare of Japan Web site. http://www.mhlw.go.jp/bunya/ kenkou/kekkaku-kansenshou04/pdf/inful-list-d .pdf. Accessed 21 June 2010.
2. Schedule of novel influenza vaccine allocation to recipient groups [in Japanese]. Ministry of Health, Labor and Welfare of Japan Web site. http://www.mhlw.go.jp/kinkyu/kenkou/influ enza/dl/infu091217-01.pdf. Accessed 21 June 2010.
3. Cessation of vaccine provision by the Ministry of Health, Labor and Welfare to a clinic in Takarazuka which gave a shot to the physician's grand-child [in Japanese]. Kobe Newspaper Web site. http://www.kobe-np.co.jp/ rentoku/shakai/ influenza09/0002611142.shtml. Published 26 December 2009. Accessed 21 June 2010.
4. McNeil MM, Broder KR, Vellozzi C, DeStefano F. Risk of fatal adverse events after H1N1 influenza vaccine: limitations of passive surveillance data. Clin Infect Dis 2010;51(7): 871-872 (in this issue).
5. Committee for Adverse Events after Novel Influenza Vaccination. Item 1-5 [in Japanese]. Ministry of Health, Labor and Welfare of Japan Web site. http://www.mhlw.go.jp/shingi/ 2010/01/dl/s0108-4e.pdf. Published 8 January 2010. Accessed 21 June 2010.
6. Committee for Adverse Events after Novel Influenza Vaccination. Item 1-6 [in Japanese]. Ministry of Health, Labor and Welfare of Japan Web site. http://www.mhlw.go.jp/shingi/ 2010/01/dl/s0108-4f.pdf. Published 8 January 2010. Accessed 21 June 2010.
7. Nakada H, Narimatsu H, Tsubokura M, et al. Risk of fatal adverse events after H1N1 influenza vaccination. Clin Infect Dis 2010; 50: 1548-1549.
8. Report on adverse events after novel influenza vaccination [in Japanese]. Ministry of Health, Labor and Welfare of Japan Web site. http://www.mhlw.go.jp/ bunya/kenkou/ kekkaku-kansenshou04/pdf/100430-01.pdf. Published 30 April 2010. Accessed 21 June 2010.
9. The tenth shipping of domestic novel influenza vaccine and the first shipping of imported vaccine [in Japanese]. Ministry of Health, Labor and Welfare of Japan Web site. http://www.mhlw.go.jp/kinkyu/ kenkou/influenza/ hourei/2010/02/dl/info 0208-02.pdf. Published 8 February 2010. Accessed 21 June 2010.
10. Special approval of imported novel influenza vaccine and initiation of vaccination for healthy adults [in Japanese]. Ministry of Health, Labor and Welfare of Japan Web site. http://www.mhlw.go.jp/bunya/kenkou/ kekkaku-kansenshou04/pdf/inful100118-01 .pdf. Published 15 January 2010. Accessed 21 June 2010.